Prof. Dato’ Sri Dr. Mike K.S. Chan, 62, Researcher, Author and Educator specialising in Biotechnology Research & Development of Stem Cells, Peptide Therapeutics, and Biological & Regenerative Medicine.

He is the founder of European Wellness Biomedical Group- Germany, a vertically integrated group comprising key divisions in IP Research & Development, Biotech & BioPharma Manufacturing Plants (Germany & EU), Educational Institutions & Professional Academies, and Global Product Distribution across 80 countries.

He owns and co-owns 40 medical wellness, diagnostics and youth restorative, hospitals, and clinics; he owns and funded Research & Development Labs in Germany, the USA, Switzerland, the UK, Turkey, and Malaysia.

Authored and co-authored about 40+ scientific and medical books, with over 70+ publications in the USA and the UK. Membership in more than 20+ academic bodies worldwide and holds 20+ international patents in stem cell, immunology, and biotech.

He sits on the Board and heads the Scientific Committee for Regenerative Medicine of ESAAM (European Society of Preventative, Regenerative and Anti-Aging Medicine) est. 2003; host the Society’s Asian Chairman; Associate Professor of AASCP-USA (American Academy of Stem Cell Physicians); Chairman of A4M-USA (American Academy of Anti- Aging Medicine) for Thailand; Chairman of Japan’s Medical Association for Regenerative Medicine, MMJ (Multi-Dimensional Holistic Medical Team Japan); and Senator of BWA- Germany (Federal Association for Economic Development & Foreign Trade for China, Indonesia and Malaysia). He is also a Healthcare Advisor to renowned SSP (Swiss Strategic Partners), Zurich.

He spearheads and collaborates with top scientists, clinicians, and scholars in research and development. He won 20+ awards for top leadership; entrepreneurship; quality assurance; lifetime achievement worldwide; several international invention awards for Biotechnology in Europe and the Middle East; and is listed in the Top 100 Influential or Prominent Chinese of the World. He has several stamps with his face in the China Postal Office and featured on the international front covers worldwide including in Chinese Foreign Trade Magazines for biotech.

Las células madre precursoras representan un avance potencial para aumentar la longevidad y revertir, al menos parcialmente, el envejecimiento. Las células madre tienen la capacidad de diferenciarse en diferentes tipos de células y ayudar a regenerar y reparar tejidos dañados o envejecidos. Al administrar células madre directamente en la zona afectada, se pueden reparar y regenerar exclusivamente el tejido dañado, dejando intactos los tejidos sanos.

Esta forma de tratamiento puede adaptarse a distintas patologías y necesidades específicas del paciente. Las células madre pueden prepararse para que se diferencien en los tipos celulares específicos requeridos para reparar el tejido dañado. Por ejemplo, en el caso de una afección cardíaca, las células madre pueden ser guiadas para desarrollarse en células miocárdicas, ayudando en la regeneración del tejido cardíaco dañado.

En general, la terapia con células madre específicamente dirigida ofrece un enfoque altamente preciso y personalizado. Aprovechando el potencial regenerativo de las células madre y dirigirlas a áreas específicas que necesitan reparación, esta forma de tratamiento tiene un gran potencial para tratar una amplia gama de enfermedades y lesiones.